Persistent Post-Cholecystectomy Syndrome Secondary to Cystic Duct Stump Calculus - A Case Report
Journal Title: JOURNAL OF MEDICAL COLLEGE CHANDIGARH - Year 2018, Vol 8, Issue 2
Abstract
Cholecystectomy is the preferred surgical treatment for cholelithiasis. However occasionally, patients continue to have symptoms even after cholecystectomy. This is now a well-defined clinical entity that is labelled as 'postcholecystectomy syndrome' (PCS). We report the case of a 42 year old female who underwent open cholecystectomy 17 years ago, and presented to us with dyspepsia and upper abdominal discomfort, especially after meals (her symptoms started within six months of cholecystectomy). Investigations revealed a calculus within a dilated cystic duct stump for which she underwent surgery and excision. The patient remains well, nearly 6 month after her operation.
Authors and Affiliations
Sahajdeep Singh Sohal, Sushma Devi Bhardwaj, Simrandeep Singh, ROBIN KAUSHIK
Persistent Post-Cholecystectomy Syndrome Secondary to Cystic Duct Stump Calculus - A Case Report
Cholecystectomy is the preferred surgical treatment for cholelithiasis. However occasionally, patients continue to have symptoms even after cholecystectomy. This is now a well-defined clinical entity that is labelled as...
Clinical and microbiological profile of patients with diabetic foot ulcer – an observational study
Objective: Diabetic foot ulcer is a major healthcare problem that is a significant cause of morbidity, mortality and financial burden. This study was conducted to determine the clinical and microbiological profile of pat...
New onset seizures in critically ill patients admitted in Intensive Care Unit: a preliminary study
We studied the aetiology of new onset seizures in 44 patients admitted to various Medical Intensive Care Units of our hospitalfrom 1st January 2014 to 30th September 2016. Results :Frequency of new onset seizures in cri...
PCSK9 Inhibitors: Changing face of dyslipidemia management
Dyslipidemia is one of the major risk factors associated with cardiovascular disease and mortality thereof. A novel drug group, PCSK9 inhibitors has been proven to be highly effective in managing difficult dyslipidemias...
Stress among junior residents in tertiary care hospitals
Not available